Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Biol Macromol ; 262(Pt 2): 130056, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38365160

ABSTRACT

It has been claimed that Dendrobium officinale polysaccharides (PSs) can degrade into oligosaccharide and then transform into short-chain fatty acids in the intestine after oral administration, and play an anti-colitis-associated cancer (CAC) effect by inhibiting intestinal inflammation. However, the material basis and core chemical structure underlying the anti-colon cancer properties of PSs have not yet been elucidated. In this study, PSs were degraded into enzymatic oligosaccharides (OSs) using ß-mannanase. The results of in vivo experiments revealed that PSs and OSs administered by gastric lavage had similar antitumor effects in CAC mice. OS-1 (Oligosaccharide compounds 1) and OS-2 (Oligosaccharide compounds 2) were further purified and characterized from OSs, and it was found that OS-1, OS-2, OSs, and PSs had similar and consistent anti-inflammatory activities in vitro. Chemical structure comparison and evaluation revealed that the chemical structure of ß-D-Manp-(1 â†’ 4)-ß-D-Glcp corresponding to OS-1 was the least common PS structure with anti-colitic activity. Therefore, our findings suggest that OSs are the material basis for PSs to exert anti-CAC activity and that the chemical structure of ß-D-Manp-(1 â†’ 4)-ß-D-Glcp corresponding to OS-1 is the core chemical structure of PSs against CAC.


Subject(s)
Colitis-Associated Neoplasms , Dendrobium , Mice , Animals , Dendrobium/chemistry , Polysaccharides/pharmacology , Polysaccharides/therapeutic use , Polysaccharides/chemistry , Oligosaccharides/chemistry , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use
2.
ChemSusChem ; 16(24): e202202370, 2023 Dec 19.
Article in English | MEDLINE | ID: mdl-37667438

ABSTRACT

The efficient decomposition of ammonia to produce COx -free hydrogen at low temperatures has been extensively investigated as a potential method for supplying hydrogen to mobile devices based on fuel cells. In this study, we employed dielectric barrier discharge (DBD) plasma, a non-thermal plasma, to enhance the catalytic ammonia decomposition over supported Ru catalysts (Ru/Y2 O3 , Ru/La2 O3 , Ru/CeO2 and Ru/SiO2 ). The plasma-catalytic reactivity of Ru/La2 O3 was found to be superior to that of the other three catalysts. It was observed that both the physicochemical properties of the catalyst (such as support acidity) and the plasma discharge behaviours exerted significant influence on plasma-catalytic reactivity. Combining plasma with a Ru catalyst significantly enhanced ammonia conversion at low temperatures, achieving near complete NH3 conversion over the 1.5 %-Ru/La2 O3 catalyst at temperatures as low as 380 °C. Under a weight gas hourly space velocity of 2400 mL gcat -1 h-1 and an AC supply power of 20 W, the H2 formation rate and energy efficiency achieved were 10.7 mol gRu -1 h-1 and 535 mol gRu -1 (kWh)-1 , respectively, using a 1.5 %-Ru/La2 O3 catalyst.

SELECTION OF CITATIONS
SEARCH DETAIL
...